These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8750726)

  • 21. Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism.
    Schmitz D; Gloveli T; Empson RM; Draguhn A; Heinemann U
    J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):119-29. PubMed ID: 9490827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
    Martin P
    Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
    Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.
    Mokrosz JL; Dereń-Wesołek A; Tatarczyńska E; Duszyńska B; Bojarski AJ; Mokrosz MJ; Chojnacka-Wójcik E
    J Med Chem; 1996 Mar; 39(5):1125-9. PubMed ID: 8676348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.
    Van den Hooff P; Galvan M
    Br J Pharmacol; 1992 Aug; 106(4):893-9. PubMed ID: 1393288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding.
    Bijak M; Tokarski K; Czyrak A; Maćkowiak M; Wedzony K
    Eur J Pharmacol; 1996 Jun; 305(1-3):79-85. PubMed ID: 8813535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged treatment with antidepressants increases the 5-HT1A-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding.
    Tokarski K; Czyrak A; Maćkowiak M; Wedzony K; Bijak M
    Acta Physiol Hung; 1996; 84(3):343-4. PubMed ID: 9219632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin and 8-OH-DPAT reduce excitatory transmission in rat hippocampal area CA1 via reduction in presumed presynaptic Ca2+ entry.
    Schmitz D; Empson RM; Heinemann U
    Brain Res; 1995 Dec; 701(1-2):249-54. PubMed ID: 8925288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDL 73005EF: partial agonist at the 5-HT1A receptor negatively linked to adenylate cyclase.
    Cornfield LJ; Nelson DL; Taylor EW; Martin AR
    Eur J Pharmacol; 1989 Dec; 173(2-3):189-92. PubMed ID: 2560432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged corticosterone treatment alters the responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons.
    Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Tokarski K; Bijak M; Wedzony K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):357-67. PubMed ID: 12237750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF; Sanger GJ
    Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.
    O'Connor JJ; Rowan MJ; Anwyl R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):158-63. PubMed ID: 8232595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.